CD8A and neoplasm: The combination treatment with TTFields and anti-PD-1 facilitated more infiltration of CD3+, CD4+ and CD8+ T cells into both the periphery and center of the tumor tissue, than anti-PD-1 treatment alone (Figs. 3b-d and 4b-d).